substance p has been researched along with Keratitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, YS; Chung, SH; Joo, CK; Kim, HS; Mok, JW | 1 |
| Chikama, T; Morishige, N; Nishida, T; Sonoda, KH; Yamada, N; Yanai, R | 1 |
| Che, CY; Hu, LT; Jiang, N; Lin, J; Wang, X; Zhao, GQ | 1 |
| Brown, SM; Khanani, AM; Reid, TW; Stetson, CL | 1 |
| Hazlett, LD; Huang, X; Lighvani, S; Swanborg, RH; Trivedi, PP | 1 |
| Choi, J; Im, SK; Jeong, TS; Park, YG; Yoon, KC; You, IC | 1 |
| Ellis, LC; Jones, MA; Marfurt, CF | 1 |
1 review(s) available for substance p and Keratitis
| Article | Year |
|---|---|
Potential New Modes of Treatment of Neurotrophic Keratopathy.
Topics: Clinical Trials as Topic; Drug Synergism; Epithelium, Corneal; Humans; Insulin-Like Growth Factor I; Keratitis; Neurotransmitter Agents; Ophthalmic Solutions; Substance P; Trigeminal Nerve Diseases | 2015 |
6 other study(ies) available for substance p and Keratitis
| Article | Year |
|---|---|
Ocular surface inflammation induces de novo expression of substance P in the trigeminal primary afferents with large cell bodies.
Topics: Animals; Apoptosis; Benzalkonium Compounds; Cell Body; Conjunctivitis; Disease Models, Animal; Epithelium, Corneal; Goblet Cells; Interleukin-1beta; Interleukin-6; Keratitis; Rats; Rats, Sprague-Dawley; Substance P; Trigeminal Ganglion; Tumor Necrosis Factor-alpha | 2020 |
[Expression of substance P in experimental fungal keratitis].
Topics: Animals; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Keratitis; Male; Rats; Rats, Wistar; Substance P | 2011 |
Vesicular eruption in a child with trigeminal nerve palsy during topical therapy with substance p and insulinlike growth factor I for neurotrophic keratitis.
Topics: Accidents, Traffic; Administration, Topical; Child, Preschool; Cornea; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Insulin-Like Growth Factor I; Keratitis; Ophthalmic Solutions; Skin Diseases, Vesiculobullous; Substance P; Trigeminal Nerve Diseases | 2004 |
Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection.
Topics: Analgesics; Animals; Cornea; Female; Immunohistochemistry; Interferon-gamma; Interleukin-18; Keratitis; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Pseudomonas Infections; Receptors, Neurokinin-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance P | 2005 |
Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cornea; Cranial Nerve Diseases; Female; Fetal Blood; Fluorophotometry; Humans; Hypesthesia; Insulin-Like Growth Factor I; Keratitis; Male; Middle Aged; Nerve Growth Factor; Ophthalmic Nerve; Ophthalmic Solutions; Prognosis; Prospective Studies; Serum; Substance P; Tears; Visual Acuity | 2007 |
Sensory and sympathetic nerve sprouting in the rat cornea following neonatal administration of capsaicin.
Topics: Adrenergic Fibers; Age Factors; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cornea; Female; Ganglia, Sympathetic; Immunoenzyme Techniques; Keratitis; Male; Myelin Sheath; Nerve Regeneration; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Substance P; Thiolester Hydrolases; Trigeminal Ganglion; Tyrosine 3-Monooxygenase; Ubiquitin Thiolesterase; Wound Healing | 1993 |